• हिन्दी
  • ગુજરાતી
  • বাংলা
  • తెలుగు
  • मराठी
  • ಕನ್ನಡ
  • money9
  • Insurance
  • Saving
  • Mutual Funds
  • Mirae Asset MF
  • Breaking Briefs
downloadDownload The App
Close
  • Home
  • Videos
  • Podcast
  • Banking
  • Bulletin
  • Gold
  • Healthcare
  • Real Estate
  • Tax
  • Travel
  • Survey 2023
  • Survey Report
  • Breaking Briefs
  • Insurance
  • Savings
  • Loan
  • Crypto
  • Investment
  • Mutual Funds
  • Real Estate
  • Tax
  • Exclusive
  • Home / Covid Update

Covid-19 Vaccination: National platform to track vaccine’s impact to be established soon

The vaccine tracker will be particularly important to monitor the impact of increasing the dosing schedule of Covishield.

  • Press Trust of India
  • Last Updated : May 14, 2021, 16:14 IST
  • Follow
Representative Image
  • Follow

New Delhi: A national tracking platform will be established soon to determine the impact of the jabs against Covid-19 and the breakthrough infections that are likely to occur among those with complete and partial immunization, official sources said.

The recommendation of the National Technical Advisory Group on Immunisation (NTAGI) to establish such a platform has been accepted by the National Expert Group on Vaccine Administration for Covid-19 and the Union Health Ministry, they said.

“The Covid-19 Working Group which is part of NTAGI has strongly recommended to urgently establish a national vaccine tracking platform to determine the impact of the Covid vaccine(s) and the breakthrough infections that are likely to occur among those with complete and partial immunisation,” said Dr. N K Arora, the INCLEN Trust chairperson who heads the Covid-19 Working Group.

The vaccine tracker will be particularly important to monitor the impact of increasing the dosing schedule of Covishield, he said, as the government on Thursday accepted the working group’s recommendation to extend the gap between the two doses of the Covishield vaccine from 6-8 weeks to 12-16 weeks.

The current data harmonization work of the Indian Council of Medical Research (ICMR) and other agencies can be leveraged to set up this facility for review of ground realities on a real-time basis, the NTAGI has recommended.

An educational tool comprising information on the risk of Covid-19 infection during pregnancy, benefits associated with the vaccination, and rare complications associated with vaccines like thrombosis and thrombocytopenia (with Covishield) may be developed.

Published: May 14, 2021, 16:13 IST

Download Money9 App for the latest updates on Personal Finance.

  • Covaxin
  • Covid-19
  • covishield

Related

  • Covid first wave led to increase in antibiotic misuse in India: Study
  • Centre rushes teams to six states reporting a high number of Covid cases
  • Covid-19: India records 46,617 new cases; national recovery rate crosses 97%
  • India’s medical infrastructure well prepared to deal with possible third Covid wave, says FM
  • Karnataka makes RT-PCR negative report, vaccine certificate must for Kerala travellers
  • National Doctors’ Day: Over 1500 doctors sacrificed their lives in fight against Covid-19

Latest

  • 1. Know the correct way to get KYC done!
  • 2. Why health insurance claim gets rejected?
  • 3. Power to Respond!
  • 4. What is Asset Under Management?
  • 5. No Worries on Medical Expenses!
  • Trending Stories

  • DGCA प्रमुख ने सुचारू उड़ान संचालन सुनिश्चित करने के लिए पायलटों से मांगा सहयोग
  • रेपो दर में कटौती से घर के लिए कर्ज होगा सस्ता, मांग बढ़ेगी: रियल एस्टेट
  • मीशो के 5,421 करोड़ रुपये के आईपीओ को दूसरे दिन मिला 7.97 गुना अभिदान
  • इंडिगो को अगले साल 10 फरवरी तक उड़ान संचालन पूरी तरह बहाल होने की उम्मीद
  • Indigo की 200 से ज्यादा फ्लाइट रद्द, हजारों पैसेंजर फंसे
  • TV9 Sites

  • TV9 Hindi
  • TV9Telugu.com
  • TV9 Marathi
  • TV9 Gujarati
  • TV9 Kannada
  • TV9 Bangla
  • TV9 English
  • News9 Live
  • Trends9
  • Tv9tamilnews
  • Assamtv9
  • Malayalamtv9
  • Money9 Sites

  • Money9 Hindi
  • Money9 English
  • Money9 Marathi
  • Money9 Telugu
  • Money9 Gujarati
  • Money9 Kannada
  • Money9 Bangla
  • Money9live
  • Topics

  • Insurance
  • Savings
  • Loan
  • Stocks
  • Mutual Funds
  • Real Estate
  • Tax
  • Crypto
  • Exclusive
  • Follow us

  • FaceBook
  • Twitter
  • Youtube
  • Instagram
  • Linkedin
  • Download App

  • play_store
  • App_store
  • Contact Us
  • About Us
  • Advertise With Us
  • Privacy & Cookies Notice
  • Complaint Redressal
  • Copyright © 2025 Money9. All rights reserved.
  • share
  • Facebook
  • Twitter
  • Whatsapp
  • LinkedIn
  • Telegram
close